Literature DB >> 4008595

The "case-control" study: valid selection of subjects.

O S Miettinen.   

Abstract

For valid selection of subjects in "case-control" (case-referent) studies it is critical to understand that these studies do not represent an alternative to cohort studies but, rather, to census-ascertainment of the facts about the study base. Specifically, in these studies, the fact-finding scheme is to obtain a census of the study base with respect to outcome, and then a census of the cases together with a sample of the base to gather information on the determinant(s) as well as modifiers and confounders. If the base is defined a priori (primary base), then the challenge is to devise a scheme to obtain a census of the cases in it and a sample of the base itself ("control" or reference series) that is representative of it, conditional on the covariates that will be controlled in the analysis of the data. On the other hand, if the definition of the base is secondary, a corollary of the way the cases are selected, then the case series is best viewed as the totality of the cases in the base as a matter of definition. The corresponding secondary base is the population experience in which each potential case, had it occurred, would have been included in the case series. Representative sampling of a secondary base tends to call for the use of subjects coming to the source of cases because of other conditions--conditions whose occurrence is known to be unrelated to the determinant under study and whose diagnosis and referral to the source are known to have the same relation to the determinant as those of the illness under study. With both types of base, primary and secondary, the accuracy of the information on the determinant should be comparable between the case and reference series, and this requirement of comparability, just as that of representativeness, can have important implications for the selection of the study subjects.

Mesh:

Year:  1985        PMID: 4008595     DOI: 10.1016/0021-9681(85)90039-6

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  33 in total

Review 1.  Design issues for drug epidemiology.

Authors:  A D McMahon; T M MacDonald
Journal:  Br J Clin Pharmacol       Date:  2000-11       Impact factor: 4.335

2.  Spouse controls in family case-control studies: a methodological consideration.

Authors:  Bas A J Verhage; Katja K H Aben; Huub Straatman; André L M Verbeek; Terri H Beaty; Lambertus A Kiemeney
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

Review 3.  Bias in case-control studies. A review.

Authors:  J A Kopec; J M Esdaile
Journal:  J Epidemiol Community Health       Date:  1990-09       Impact factor: 3.710

Review 4.  Epidemiology research in rheumatology-progress and pitfalls.

Authors:  Deborah P M Symmons
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

Review 5.  Case-control studies in pharmacoeconomic research: an overview.

Authors:  J Jaime Caro; Krista F Huybrechts
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

6.  Bipolar disorder and related mood states are not associated with endothelial function of small arteries in adults without heart disease.

Authors:  Brian Tong; Oluchi Abosi; Samantha Schmitz; Janie Myers; Gary L Pierce; Jess G Fiedorowicz
Journal:  Gen Hosp Psychiatry       Date:  2017-12-19       Impact factor: 3.238

7.  Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma.

Authors:  James R Cerhan; Zachary S Fredericksen; Alice H Wang; Thomas M Habermann; Neil E Kay; William R Macon; Julie M Cunningham; Tait D Shanafelt; Stephen M Ansell; Timothy G Call; Thomas E Witzig; Susan L Slager; Mark Liebow
Journal:  Int J Mol Epidemiol Genet       Date:  2011-04-05

Review 8.  Methodologic issues in injury case-control studies.

Authors:  I Roberts
Journal:  Inj Prev       Date:  1995-03       Impact factor: 2.399

9.  Current smoking and the risk of non-fatal myocardial infarction in the WHO MONICA Project populations.

Authors:  M S Mähönen; P McElduff; A J Dobson; K A Kuulasmaa; A E Evans
Journal:  Tob Control       Date:  2004-09       Impact factor: 7.552

10.  Well shaped ST segment and risk of cardiovascular mortality.

Authors:  E G Schouten; J M Dekker; J Pool; F J Kok; M L Simoons
Journal:  BMJ       Date:  1992-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.